台灣消化系外科醫學會
歷屆理監事/委員
www.tssg.org.tw image
 
image
  
image會員登入
image會員教育積分查詢
image會員繳費查詢
image會員資料修改
image會員密碼變更
image會員通訊錄
image台灣消化系外科專科醫師訓練計畫及訓練課程基準
image消化外科專科醫師換證及展延申請
image住院醫師優秀論文獎及年輕主治醫師傑出研究獎辦法
image檔案下載
lineline
line
回首頁 > 2013冬季會論壇 > Management of Acute Abdomen with Acute Care Surgery (ACS) Service Model  > Imatinib: Delivering High-Quality Cancer Treatment   發佈主題 發佈主題  |  搜尋本區 搜尋本區
 | 回覆文章 回覆文章
討論區image  作者  Imatinib: Delivering High-Quality Cancer Treatment
daisymiller 
張貼日期: 2025/2/10 下午 01:14:37

Imatinib is a groundbreaking targeted therapy used to treat various cancers, primarily chronic myeloid leukemia (CML) and gastrointestinal stromal tumors (GISTs). As a tyrosine kinase inhibitor (TKI), it works by blocking the abnormal proteins responsible for cancer cell growth, effectively halting disease progression. Unlike traditional chemotherapy, Imatinib selectively targets cancer cells while minimizing damage to healthy tissues, resulting in fewer side effects and improved patient outcomes.

The availability of high-quality generic imatinib manufacturers ensures a consistent supply of this life-saving drug at an affordable cost. These manufacturers adhere to stringent regulatory standards to produce safe and effective medication for global distribution.

Clinical studies have demonstrated Imatinib's efficacy in achieving long-term remission, significantly increasing survival rates for CML and GIST patients. It is often used as a first-line treatment, revolutionizing cancer care by turning once-fatal diagnoses into manageable conditions. Research continues to explore its potential in treating other malignancies, further expanding its role in oncology.

With continuous advancements and strong support from pharmaceutical manufacturers, Imatinib remains a cornerstone of targeted cancer therapy, offering hope and an improved quality of life for countless patients worldwide.


回首頁 > 2013冬季會論壇 > Management of Acute Abdomen with Acute Care Surgery (ACS) Service Model  > Imatinib: Delivering High-Quality Cancer Treatment   發佈主題 發佈主題  |  搜尋本區 搜尋本區
 | 回覆文章 回覆文章
討論區image討論區image 回覆此文章
您的姓名:
電子信箱:
自動通知: 當有人回覆時通知我
回覆問題:
驗證碼:
驗證碼   (若難以辨識,請按重新產生)
    輸入您在上圖中看到的字元。



line
lineline
 
image
  image
 
       首頁   隱私權政策  
 
 
台灣消化系外科醫學會
qrcode
Taiwan Surgical Society Of Gastroenterology
TEL:886-2-2370-5679        Fax:886-2-2370-7687        Email:tssgorg@gmail.com;tssg.org.2@gmail.com
10041臺北市中正區忠孝西路一段50號17樓之15
17F-15, No. 50, Chung-Hsiao W. Rd., Sec. 1, Chung-Cheng District, 10041, Taipei, Taiwan, R. O. C
郵政劃撥帳號:18858447 戶名:社團法人台灣消化系外科醫學會